Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Salba Corporation is a functional food and clinical nutrition company that specializes in the development and commercialization of Salba (Salvia hispanica L.), a proprietary variety of white chia seed. The company has pioneered the use of Salba as a medical food, supported by randomized controlled trials demonstrating its efficacy in reducing cardiovascular risk factors and improving glycemic control in patients with type 2 diabetes. Salba is distinguished by its high content of Omega-3 fatty acids (ALA) and dietary fiber, and the company maintains exclusive rights to the cultivation and distribution of this specific grain variety. Its products are marketed globally, primarily through its North American affiliate, Salba Smart Natural Products, and are used as both standalone supplements and ingredients in various health-focused food products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Salba Corporation.